As of 2026-05-26, the Intrinsic Value of Jointown Pharmaceutical Group Co Ltd (600998.SS) is 6.31 CNY. This 600998.SS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 4.79 CNY, the upside of Jointown Pharmaceutical Group Co Ltd is 31.70%.
The range of the Intrinsic Value is 4.74 - 8.66 CNY
Based on its market price of 4.79 CNY and our intrinsic valuation, Jointown Pharmaceutical Group Co Ltd (600998.SS) is undervalued by 31.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 4.74 - 8.66 | 6.31 | 31.7% |
| DCF (Growth 10y) | 6.43 - 10.89 | 8.22 | 71.6% |
| DCF (EBITDA 5y) | 7.80 - 10.49 | 9.05 | 88.9% |
| DCF (EBITDA 10y) | 9.59 - 13.28 | 11.28 | 135.4% |
| Fair Value | 2.00 - 2.00 | 2.00 | -58.23% |
| P/E | 4.77 - 5.74 | 5.06 | 5.6% |
| EV/EBITDA | 3.32 - 5.48 | 4.49 | -6.2% |
| EPV | 2.94 - 4.71 | 3.83 | -20.1% |
| DDM - Stable | 2.67 - 5.30 | 3.99 | -16.8% |
| DDM - Multi | 5.04 - 7.57 | 6.04 | 26.1% |
| Market Cap (mil) | 24,153.43 |
| Beta | 0.75 |
| Outstanding shares (mil) | 5,042.47 |
| Enterprise Value (mil) | 43,325.43 |
| Market risk premium | 6.13% |
| Cost of Equity | 9.14% |
| Cost of Debt | 5.00% |
| WACC | 7.10% |